Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1 (Q27639371)

5

0 references

Q42873701

object named as

Jianping Ding

1

0 references

author name string

Allen D Smith

2

0 references

Sheila C Geisler

3

0 references

Xuejun Ma

Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

4

0 references

publication date

July 2002

0 references

published in

Structure

0 references

volume

10

0 references

issue

7

0 references

page(s)

999-1011

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Variable and conserved neutralization antigens of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Jitters jeopardize AIDS vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Crystal structure of the principal neutralization site of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure of a human common cold virus and functional relationship to other picornaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

PROCHECK: a program to check the stereochemical quality of protein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

A modified ELISA that selectively detects monoclonal antibodies recognizing native antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Crystal structure of human rhinovirus serotype 1A (HRV1A)

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The structure of human rhinovirus 16

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Implications for viral uncoating from the structure of bovine enterovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure of the expanded state of tomato bushy stunt virus

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structures of the native and swollen forms of cowpea chlorotic mottle virus determined by X-ray crystallography and cryo-electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The interpretation of protein structures: Estimation of static accessibility

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Structure of the heat shock protein chaperonin-10 of Mycobacterium leprae

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Crystal structure of toxin II from the scorpion Androctonus australis Hector refined at 1.3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Solution structure of the V3 loop of a Thailand HIV isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Local and global structural properties of the HIV-MN V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Cyclic V3-loop-related HIV-1 conjugate vaccines. Synthesis, conformation and immunological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

1 reference

7 January 2021

Solvent content of protein crystals

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Accurate bond and angle parameters for X-ray protein structure refinement

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021

Human rhinovirus 3 at 3.0 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0969-2126%2802%2900793-1

7 January 2021